NCT04495738终止不适用
Infant Formula and Toddler Drink Feeding Intervention Through 24 Months of Age
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 168
- 试验地点
- 54
- 主要终点
- Incidence of respiratory infection between study groups
研究概览
简要总结
The purpose of this randomized, multi-center, controlled, double-blind, parallel study is to evaluate the health and developmental outcomes of children fed a new infant formula and toddler drink through 24 months of age.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- — 至 14 Days（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Participant is judged to be in good health as determined from participant's medical history
- •Participant is a singleton from a full-term birth with a gestational age of 37 - 42 weeks
- •Participant's birth weight was ≥ 2490 g (~5 lbs. 8 oz.)
- •If parent(s) elect to formula feed the participant they confirm their intention to feed their participant the study product as the sole source of feeding until 4 months of age, and as the sole milk beverage during the first 12 months of life
- •If parent(s) elect to formula feed the participant, they confirm their intention to feed the participant the assigned toddler drink from 12 months of life to 24 months of life as the primary milk beverage
- •If parent(s) elect to feed the participant mother's human milk, they confirm that their infant was exclusively fed mother's human milk since birth and confirm their intention to continue exclusively feeding human milk as the sole source of feeding through 4 months of age
- •If parent(s) of human milk fed participant elect to supplement or wean after 4 months to 24 months of age, they confirm their intention to use the supplemental/weaning formula or toddler drink as the primary milk beverage
- •Parent(s) of formula-fed participant confirm their intention not to administer vitamin or mineral supplements, from enrollment through the duration of the study
- •Parent(s) confirm their intention not to administer solid foods or juices to the participant from enrollment through 6 months of age
- •Participant's parent(s) has voluntarily signed and dated an informed consent form (ICF), approved by an Institutional Review Board/Independent Ethics Committee (IRB/IEC) and provided Health Insurance Portability and Accountability Act (HIPAA) (or other applicable privacy regulation) authorization prior to any participation in the study.
排除标准
- •An adverse maternal, fetal or participant medical history that is thought by the investigator to have potential for effects on tolerance, growth, and/or development
- •Participant is taking and plans to continue medications (including over the counter (OTC), home remedies, herbal preparations, prebiotics or probiotics, or rehydration fluids that might affect GI tolerance
- •Participant is in another study that has not been approved as a concomitant study
- •Participant has been treated with antibiotics prior to enrollment
结局指标
主要结局
Incidence of respiratory infection between study groups
时间窗: Study Day 1 to 6 Months of Age
Adverse event reports
次要结局
- Infection morbidity between study groups(Study Day 1 to 24 Months of Age)
研究者
研究点 (54)
Loading locations...
相似试验
已完成
不适用
Effect of an Infant Formula With Synbiotics in Infants Born Via Caesarean SectionGut MicrobiotaNCT04991792HiPP GmbH & Co. Vertrieb KG486
已完成
不适用
The Impact of a Novel Infant Formula on Immunity, Gut Health and GrowthHealthy Term InfantNCT06686433Biostime (Guangzhou) Health Products Limited342
已完成
不适用
Safety and Efficacy of an Infant Formula Supplemented With Galacto-oligosaccharides, Beta-palmitate and Acidified MilkFormula Feeding of Healthy Full Term InfantsNCT01197365Heinz Italia SpA148
已完成
不适用
The Trial of a New Infant Formula in Healthy Term Chinese InfantsHealthy InfantsNCT06053112Junlebao Dairy Group Co., Ltd.326
已完成
不适用
Safety and Efficacy of an Infant Formula Supplemented With Galacto-oligosaccharides (GOS)Nutritional SafetyNCT00486148Heinz Italia SpA360